Pitch  & Partner

 

 

As funding remains a major hurdle for antibiotic and rapid diagnostics development, hear the perspective of current funding agencies and initiatives such as CARB-X, GARDP, and AMR Centre, as well as successful partnering and capital case studies that contributed to advancing the development of innovative antimicrobials and rapid tests. Over 20+ cutting edge biotechs, academic innovators and diagnostics developers will be presenting new data to prospective funders and partners.

 

Presentations

 

Pitches

Pitch and Partner, Thursday 7 November 2019

Kevin Outterson
08:30

Keynote Address: A vision for a healthy antibiotic R&D ecosystem

Concrete Commercial Initiatives

Jonathan Van-Tam
08:40

Keynote address: UK’s efforts to combat resistance and create a sustainable commercial environment for existing and future antibiotics

09:20

Sponsored keynote address

TITLE SPONSOR SLOT
10:20

SPEED NETWORKING FOLLOWED BY NETWORKING COFFEE BREAK

Funding & Innovation

Karen Gallant
Pitch and Partner
11:15

CARB-X – Accelerating innovation to fight drug-resistant bacteria

Mark Engel
Pitch and Partner
11:35

Utilizing Bacteriophages to Prevent Infections: An Update

Alexander Belcredi
Pitch and Partner
11:55

Developing phage drugs as first-line therapies

Malcolm Thomas
Pitch and Partner
12:05

Overcoming bacterial resistance through a new and unique mode of action

David Luci
Pitch and Partner
12:15

ACX-362E and ACX-375C to treat serious and life- threatening bacterial infections

David Luci, Chief Executive Officer, Acurx Pharmaceuticals
Greg Merril
Pitch and Partner
12:25

PhageBank - Advancing personalized phage therapy from niche to broad market scale

12:35

Networking Lunch Break

ROUNDTABLES (1-hour roundtable sessions split between 2 rounds of 30min)

Ryan Devies
14:10

Roundtable: Advancing Preclinical – working with regulators through pre-clinical to advance distinct classes of small molecule drugs

Colm Leonard
14:10

Roundtable: Antimicrobial value assessment - a look into the role of HTA in the UK's testing of novel assessment and delinked payment program

Marco Taglietti
14:10

Roundtable: Candida auris - a ticking time bomb: responding to an urgent global public health threat

Kartik Cherabuddi
14:10

Roundtable: Controlling c.dif - determining who to test and how to prevent additional outbreaks in the hospital

Justine Ross
14:10

Roundtable: Customizing Epic – the use of Epic Stewardship Navigator to aid antimicrobial stewardship, pharmacist workflow, and prescribing habits in a tertiary cancer center

Richard Vickers
14:10

Roundtable: Innovation & stewardship

Advancing narrow spectrum, new mechanism antibiotics as precision agents to by-pass resistance and to support antibiotic stewardship. Developing the right antibiotic to treat the right patient and improve clinical outcomes.
Christine Årdal
14:10

Roundtable: Market Access - overcoming access barriers for smaller markets - considerations for countries and developers

Brian Tse
14:10

Roundtable: Non-traditional antibacterials – advancing non-traditional product types from discovery phase to clinical development

Christian Lillis
14:10

Roundtable: Patient Advocacy - what can the growing antibiotic patient advocacy community do to generate public awareness and support for AMR initiativ

Dave Ousterout
14:10

Roundtable: Phage development - Opportunities in development of novel phage therapies

Jay K Varma
14:10

Roundtable: Policy in Africa- advancing advocacy, political commitment, resistance data collection and Africa-wide stewardship guidelines for antimicrobial use in humans

Jane Knisely
14:10

Roundtable: Supporting development

NIH programs filling the gaps in traditional and non-traditionaltherapeutic discovery & development with grants, contracts,in-vitro and in vivo screening and manufacturing capabilities and more.
Amy Kirby
14:10

Roundtable: Water Quality – understanding transmission of waterborne pathogens and how the international community can combat the spread of resistance through integrating advanced lab techniques and t

Amy Kirby, Senior Service Fellow, Microbiologist, Waterborne Disease Prevention Branch DFWED-NCEZID, CDC

Funding & Partnerships

Jean-Pierre Paccaud
Pitch and Partner
15:15

Leveraging sources of public funding to meet gaps in S&M antibiotic financing

How can we avoid the catastrophic disappearance of S&M companies and their unique competencies in antibiotic discovery and development.
Peter Jackson
Pitch and Partner
15:35

UK Centre of Excellence - a global resource for pre-clinical and clinical development, and mobilizing public, private and philanthropic investment

Neil Clark
Pitch and Partner
15:55

XF-73 for the prevention of post-surgical staphylococcal infections

Rusty Bromley
Pitch and Partner
16:05

A novel immunotherapy to fight infection and inflammation

Marc Lemonnier
Pitch and Partner
16:15

Antabio SAS: novel antibacterials targeting critical priority MDR gram-negative pathogens

Marc Gitzinger
Pitch and Partner
16:25

BV100 to treat serious bacterial infections by A.baumannii

16:35

Networking coffee break

Supported by BD

18:15

Drinks Reception

last published: 31/Jul/19 21:55

Pitch and Partner, Friday 8 November 2019

Tom Lowery
09:25

Sponsored keynote address will be delivered by T2 Biosystems

10:30

Networking coffee break

Investment

Maria Nagy
Pitch and Partner
11:55

Quorum X Diagnostics: A new way of identifying bacteria, without the need for culture or DNA amplification

Matthew Gombrich
Pitch and Partner
12:05

Aperture Bio empiriSTAT UTI: A rapid, direct-out-of-urine method for addressing the rise in antibiotic resistance in urinary tract infections

Piotr Garstecki
Pitch and Partner
12:15

Bacteromic: Intelligence for precision therapies against antimicrobial resistance

Monique Van Hoek
Pitch and Partner
12:25

Discovery of Antimicrobial peptides from Alligator and Komodo Dragons against multi-drug resistant bacteria

12:35

Networking Lunch Break

13:40

Networking Lunch Break Resumes

ROUNDTABLES (1-hour roundtable sessions split between 2 rounds of 30min)

Minh-Hong Nguyen
14:10

Developing diagnostics – novel approaches to development

Minh-Hong Nguyen, Director, Transplant Infectious Diseases, Director, Antimicrobial Management Program, University of Pittsburgh
Eugean Jiwanmall
14:10

Roundtable: Evaluating Diagnostics – Criteria for potential coverage and related decisions - paths for generating, formalizing, & analysing evidence to build & reach consensus

Thomas Heymann
14:10

Roundtable: AMR and Sepsis - we are all in this together

Jeanette Mucha
14:10

Roundtable: CARB-X Accelerator – Company perspective on CARB-X Accelerator - What worked and what can be improved?

Abigail Colson
14:10

Roundtable: Health Technology Assessment – when it comes to AMR, will HTA be part of the solution or part of the problem?

Lee Jones
14:10

Roundtable: Infection intervention - Using the microbiome to make antibiotics effective again

Angella Browne
14:10

Roundtable: Infection prevention – next wave of infection prevention of multidrug resistant infections through screening, protocol and more

Clifford Mcdonald
14:10

Roundtable: Microbiome & CDC – Discussing a vision for precision public health novel approaches to treating infection prevention through the microbiome

Mary Millard
14:10

Roundtable: Patient practitioner education – how hospitals can and should educate patients on infection risks and easy to implement prevention practices

Eili Klein
14:10

Roundtable: Surveillance

Examining novel metrics for measurement, societal and socioeconomic factors effecting resistance, and how resistance surveillance tools can help educate policymakers on AMR.
Nick Van Hise
14:10

Roundtable: The fecal microbiome - new approaches to the treatment of C. difficile infection

Wes Kim
14:10

SPARK Platform: Pew Charitable Trusts’ Collaborative Discovery Tool for Gram-Negative Antibiotics

last published: 31/Jul/19 21:55

 

 


GET INVOLVED AT

WORLD ANTI-MICROBIAL RESISTANCE CONGRESS

 

To Sponsor Or Exhibit

 


André Singer
andre.singer@terrapinn.com
+1 646.619.1797

 

 

Press & Media Partnerships

 


Shannon McGorry
shannon.mcgorry@terrapinn.com
+1 646.619.1840

 

 

To Speak

 


Claire Murphy
claire.murphy@terrapinn.com
+1 646.619.1784

 

Sign Up for Event Updates